Minerva Neurosciences IPO Research Information

Minerva Neurosciences IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Minerva Neurosciences, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Minerva Neurosciences	NERV - NASDAQ	$10.00-$12.00	$6.00	$6.00	5.5 million	7/1/2014
Underwriter(s): Jefferies
Co-Manager(s): Baird, JMP Securities
Industry: Health Care
Filing(s): Filed 2014-04-10 Terms Added 2014-06-10

Minerva Neurosciences Quote & Chart - Click for current quote - NERV

About Minerva Neurosciences (adapted from Minerva Neurosciences prospectus):
They are a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system, or CNS, diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "NERV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.